With improvements in the tools and technologies that enable deeper analysis of the skin microbiome, the community's understanding of the skin microbiome is becoming clearer. This has led to the development of a number of breakthrough dermatological, skincare and cosmetic solutions that tap into this ecosystem on our skin for improved health.
However, there still exists a number of unique areas of basic and clinical science within the skin microbiome field that need addressing before the true potential of this field is realized.
Celebrating our fourth year, the Microbiome Movement - Skin Health and Dermatology Summit continues to unite researchers from academia and industry to address the unique areas of scientific R and D, as well as the consumer interfacing aspect of this industry. Bringing together 25+ expert speakers and 100+ key decision makers across 3 days, we will hasten the development of microbiome-targeting therapeutics and cosmetics through a series of presentations, panel discussions and networking opportunities.
Join us to fast-track the development of microbiome-targeting therapeutics and cosmetics that focus on characterization, clinical testing and product commercialization.
Tightly focused on translating academic discussions into cosmetic and therapeutic development, this unrivalled program addresses the latest scientific findings and key translational challenges to aid the development of your scientifically validated skin microbiome products so you can bring them to the hands of patients and consumers faster.
Running digitally August 3-5, 2021.
Group discounts and early booking rates are available. Please visit the website for full pricing information.
Conference + Focus Day (Industry): USD 2248.0,
Conference Only (Industry): USD 1649.0,
Conference + Focus Day (Service Provider): USD 2748.0,
Conference Only (Service Provider): USD 2049.0,
Conference + Focus Day (Academic): USD 1608.0,
Conference Only (Academic): USD 1109.0
Speakers: Assaf Oron, CBO, BiomX, Barbara Paldus, CEO, Codex Beauty, Cheri Ackerman, CEO, Concerto Biosciences, Nicole Scott, Founder and CEO, Cybele Microbiome, Elsa Jungman, Founder and CEO, Dr. Elsa Jungman, Xavier Duportet, CEO, Eligo Bioscience, Trevor Steyn, Founder, ESSE Probiotic Skincare, Linda Katz, Director, FDA, Office of Cosmetics and Colors, Chris Callawaert, Senior Postdoctoral Researcher, Ghent University, Skyler Stein, President, Gladskin, Joan Attia, Global R and D Director, IFF - Lucas Meyer Cosmetics, Evelina Vagesjo, CEO and Co-Founder, Ilya Pharma, Enea Di Domenica, Senior Researcher, Isituti Fisioterapici Ospitalleri, Andrea Timm, Senior Research Scientist, John Hopkins University - Applied Physics Lab, Soren Kjaeruff, CEO, Lactobio, Philippe Calais, CEO, MatriSys Bioscience, Paula Simpson, Author, Formulation and Branding Expert, Founder Nutribloom Consulting, Natalise Kalea Robinson, CEO, Parallel Health, Yug Varma, CEO, Phyla, Jay Tiesman, Genomics Group Leader, Procter and Gamble, Emma Taylor, CMO, Symbiome, Larry Weiss, Chief Science and Product Officer, Symbiome, Denise Herich, Co-Founder and Managing Partner, The Benchmarking Company, Katerina Steventon, Innovation Consultant, The National Biofilms Center, Jason Harcup, Global VP Personal Care Research and Global VP Prestige, Unilever, Bernhard Homey, Professor, University Hospital Dusseldorf
Time: 09:00 - 16:00